Latest press releases
EnginZyme Raises €21 Million in Series B to Accelerate the Commercialisation of Its Cell-Free Biomanufacturing Technology
STOCKHOLM--(BUSINESS WIRE)--EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced today that it had raised €21 million in a Series B financing round. New investors, including Almi Invest GreenTech, Navigare Ventures and Bunge Ventures, join existing investors Sofinnova Partners, Industrifonden and SEB GreenTech VC in the funding round.
How Artificial Intelligence is pushing biobased chemistry forward
Q&A WITH MARTIN ENGQVIST, ENGINZYME’S GROUP LEADER FOR COMPUTATIONAL ENZYME DESIGN EnginZyme is on a mission to change chemistry for good by providing reliable, cost-effective and scalable biomanufacturing solutions. Traditional chemical manufacturing demands a lot of energy and creates too much waste. Using biobased starting materials and enzyme catalysts is a big step in the right direction for the industry. As the head of EnginZyme’s computational enzyme design group, Martin Engqvist leads ...